OTTONE, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 7.255
EU - Europa 1.378
AS - Asia 344
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 2
Totale 8.996
Nazione #
US - Stati Uniti d'America 7.248
IT - Italia 634
KR - Corea 176
PL - Polonia 172
IE - Irlanda 160
CN - Cina 119
FR - Francia 111
DE - Germania 93
GB - Regno Unito 64
UA - Ucraina 61
SE - Svezia 21
RU - Federazione Russa 17
FI - Finlandia 16
IN - India 15
CA - Canada 7
JP - Giappone 7
HK - Hong Kong 6
CH - Svizzera 5
NL - Olanda 5
BE - Belgio 4
ES - Italia 4
EU - Europa 4
MY - Malesia 4
AU - Australia 3
BR - Brasile 3
CO - Colombia 3
IR - Iran 3
BD - Bangladesh 2
GR - Grecia 2
HU - Ungheria 2
LU - Lussemburgo 2
PK - Pakistan 2
SG - Singapore 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SD - Sudan 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.996
Città #
Wilmington 1.854
Houston 1.768
Woodbridge 1.452
Fairfield 355
Chandler 340
Ashburn 191
Kraków 171
Cambridge 153
Seattle 153
Rome 144
Dublin 141
Ann Arbor 140
Medford 101
New York 82
Dearborn 77
Milan 57
Lawrence 49
Jacksonville 40
Beijing 35
Engelhard 22
San Diego 21
Zhengzhou 20
Creede 17
Boardman 16
Perugia 16
Menlo Park 14
Seoul 14
Center 13
Hackensack 13
Frankfurt am Main 12
London 12
Palermo 12
Bari 9
Norwalk 9
Bologna 8
Florence 8
Hefei 8
Redwood City 7
Toronto 7
Genoa 6
Guangzhou 6
Kilburn 6
Kunming 6
Nanchang 6
Washington 6
Genova 5
Hangzhou 5
Marseille 5
Pisa 5
Shenzhen 5
Turin 5
Vicenza 5
Bagnolo Mella 4
Brescia 4
Cagliari 4
Casorate Primo 4
Ferrara 4
Hong Kong 4
Naples 4
Paris 4
San Francisco 4
San Giovanni in Persiceto 4
Shanghai 4
Verona 4
Barbariga 3
Bergamo 3
Bolzano 3
Campobasso 3
Civita Castellana 3
Kuching 3
Lappeenranta 3
Modena 3
Mountain View 3
Napoli 3
Nuremberg 3
Pune 3
Redditch 3
Reggio Nell'emilia 3
Salerno 3
Tokyo 3
Torino 3
Venezia 3
Venice 3
Ahmedabad 2
Alcamo 2
Ancona 2
Arona 2
Arvada 2
Azzano San Paolo 2
Billings 2
Brussels 2
Budapest 2
Bulandshahr 2
Camparada 2
Castel San Pietro Terme 2
Castelnuovo Rangone 2
Castelnuovo di Val di Cecina 2
Castiglione delle Stiviere 2
Central 2
Chengdu 2
Totale 7.771
Nome #
La mutazione di tipo A della nucleofosmina nella diagnosi e nel follow-up della leucemia mieloide acuta 577
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups 422
Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy 415
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23) 409
PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 409
Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation 400
The hidden genomic landscape of acute myeloid leukemia: Subclonal structure revealed by undetected mutations 399
Clonal evolution in therapy-related neoplasms 391
Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells 376
Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders 365
Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia 357
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 344
Erratum: Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups (Blood Cancer Journal (2013) 3 (e147) DOI:10.1038/bcj.2013.46) 330
Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia 309
Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia 283
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy 269
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 261
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia 245
The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells 221
Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse 219
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes 182
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 173
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 168
MRD in AML: The Role of New Techniques 166
Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia 153
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 133
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells 132
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial 110
Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia 105
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation 64
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia 58
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 57
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes 52
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML 51
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression 48
Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient 43
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 43
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 40
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C 38
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib 36
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia 35
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 34
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol 33
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis 30
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 28
Case report: very late, atypical extra-medullary relapse in a patient with acute promyelocytic leukemia (APL) rescued with a transplant-free approach 25
New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia 25
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways 24
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia 23
Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient 19
Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells 19
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 19
An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone 18
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19 18
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 17
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype 15
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 15
The response to oxidative damage correlates with driver mutations and clinical outcome in patients with myelofibrosis 14
Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations 12
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells 7
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation 7
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells 5
Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection 3
Totale 9.298
Categoria #
all - tutte 24.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019206 0 0 0 0 0 0 0 0 0 0 0 206
2019/20202.443 176 153 170 216 184 240 309 229 241 218 146 161
2020/20211.607 144 151 171 205 197 150 196 150 62 85 74 22
2021/2022568 13 30 40 14 17 49 20 44 48 49 49 195
2022/2023975 96 67 59 129 61 174 146 58 91 15 38 41
2023/2024627 92 18 91 42 56 136 50 33 35 26 18 30
Totale 9.298